KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Operating Leases (2019 - 2026)

West Pharmaceutical Services has reported Operating Leases over the past 8 years, most recently at $113.4 million for Q1 2026.

  • Quarterly Operating Leases rose 12.72% to $113.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $113.4 million through Mar 2026, up 12.72% year-over-year, with the annual reading at $95.6 million for FY2025, 16.87% up from the prior year.
  • Operating Leases was $113.4 million for Q1 2026 at West Pharmaceutical Services, up from $95.6 million in the prior quarter.
  • Over five years, Operating Leases peaked at $113.4 million in Q1 2026 and troughed at $77.2 million in Q3 2022.
  • The 5-year median for Operating Leases is $87.3 million (2023), against an average of $90.9 million.
  • Biggest five-year swings in Operating Leases: soared 47.62% in 2022 and later dropped 9.14% in 2023.
  • Tracing WST's Operating Leases over 5 years: stood at $93.0 million in 2022, then fell by 9.14% to $84.5 million in 2023, then decreased by 3.2% to $81.8 million in 2024, then rose by 16.87% to $95.6 million in 2025, then rose by 18.62% to $113.4 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods came in at $113.4 million, $95.6 million, and $94.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.